Newsroom

WIEN--(BUSINESS WIRE)--Die Alpega Group, einer der führenden paneuropäischen Anbieter integrierter Transport- und Logistikplattformen, gibt heute eine geplante Veränderung in der Unternehmensführung bekannt. Nach einer erfolgreichen Amtszeit als CEO geht Todd DeLaughter in den Ruhestand, bleibt dem Unternehmen jedoch als Berater des Boards erhalten. Der Verwaltungsrat hat Daniel Cohen mit Wirkung zum 1. Januar 2026 zum neuen CEO ernannt. Daniel Cohen bringt über drei Jahrzehnte Erfahrung in der...

VIENNE--(BUSINESS WIRE)--Le groupe Alpega, l'un des principaux fournisseurs paneuropéens de plateformes de transport et de logistique intégrées, annonce aujourd’hui une transition planifiée de sa direction. Après un mandat en tant que Directeur Général, Todd DeLaughter prend sa retraite, quitte ses fonctions et devient membre du Conseil d'Administration de l’entreprise. Le Conseil d'Administration a nommé Daniel Cohen au poste de Directeur Général, à compter du 1er janvier 2026. Daniel Cohen ap...

VIENNA--(BUSINESS WIRE)--Alpega Group, a leading pan-European provider of an end-to-end transportation and logistics platform, today announced a planned leadership transition. After a successful tenure as Chief Executive Officer, Todd DeLaughter will be retiring, stepping down from his role and transitioning to a Board Advisor role for the company. The Board of Directors has appointed Daniel Cohen as the incoming CEO, effective January 1st, 2026. Daniel Cohen brings three decades of experience...

NEW YORK--(BUSINESS WIRE)--Luvme Hair, a trusted brand in colored human hair wigs and glueless lace wig, is kicking off the year with its 2026 New Year New Look Offers. Aligned with Luvme’s 2026 brand theme, Better Hair, Easy Care, this seasonal event makes it easier than ever for customers to upgrade their look with premium styles starting at just $74.9. Designed to be effortless, reliable, and comfortable, with these limited-time offers, shoppers can welcome the new year with confidence, disc...

PARIS--(BUSINESS WIRE)--Die Endpoint Detection & Response-Platform (EDR) des Cybersicherheitsanbieters HarfangLab wurde als erstes EDR-Produkt vom BSI zertifiziert....

PORTO, Portugal--(BUSINESS WIRE)--FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026 in San Francisco, CA. With more than a decade of expertise, FJBio has supported over 250 clients across Pharma, Biotech and Academia and contributed to more than 19 antibodies advancing to clinical stage developme...

LOS ANGELES--(BUSINESS WIRE)--Active Membranes appointed Eric Hoek, PhD, as Executive Chairman to support strategy, commercialization, and fundraising....

DALLAS--(BUSINESS WIRE)--Logile, Inc., the leading provider of AI-driven workforce and store operations solutions, today announced that AF Blakemore & Son Ltd, one of the UK’s largest privately owned family businesses, has chosen Logile’s Labour Planning suite to unify its workforce management and standardise labour practices across its retail operations. AF Blakemore, which operates more than 240 SPAR stores and serves over 900 communities through its wholesale network across England and W...

HANOI, Vietnam--(BUSINESS WIRE)--Global IT Corporation FPT announced its appointment as the inaugural Global Elite Reseller under a new initiative from Sitecore that expands upon its successful Global Reseller Program. The Global Elite Reseller Program follows the launch of SitecoreAI, the next-generation digital experience platform that puts artificial intelligence at the center of marketing, unifying content, data, and personalization in one composable platform so organizations can reach, eng...

BERLIN & BOSTON--(BUSINESS WIRE)--Bayer and Soufflé Therapeutics™, an innovative biotech company that discovers and develops cell-selective genetic therapies, today announced a strategic collaboration and global licensing agreement to advance a heart-targeted small interfering RNA (siRNA) therapy. The companies will collaborate to develop a siRNA-based treatment for a form of dilated cardiomyopathy, addressing a rare subset of heart disease. "We are excited to partner with Soufflé and begin exp...